# Official Journal C 29/2021

| | ISSN 1977-091X |
| --- | --- |
| Official Journal
  of the European Union | C 29 |
| | |
| English edition | Information and Notices | Volume 6426 January 2021 |

ISSN 1977-091X

Official Journal

of the European Union

C 29

English edition

Information and Notices

Volume 6426 January 2021

---

| Contents | page |
| --- | --- |
| | II   Information |
| | INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
| | European Commission |
| 2021/C 29/01 | Non-opposition to a notified concentration (Case M.10066 — Carlyle/Flender) (
  1
  ) | 1 |

Contents

page

II   Information

INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

2021/C 29/01

Non-opposition to a notified concentration (Case M.10066 — Carlyle/Flender) (
  1
  )

1

1

---

| | IV   Notices |
| --- | --- |
| | NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
| | European Commission |
| 2021/C 29/02 | Euro exchange rates — 25 January 2021 | 2 |
| | NOTICES FROM MEMBER STATES |
| 2021/C 29/03 | Winding-up proceedings – Winding-up proceedings in respect of Nederlandsche Algemene Maatschappij van Levensverzekering Conservatrix N.V. (the Company)
  (Publication made in accordance with Article 280 of Directive 2009/138/EC of the European Parliament and of the Council on the taking up and pursuit of the business of Insurance and Reinsurance (Solvency II)) | 3 |

IV   Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

2021/C 29/02

Euro exchange rates — 25 January 2021

2

NOTICES FROM MEMBER STATES

2021/C 29/03

Winding-up proceedings – Winding-up proceedings in respect of Nederlandsche Algemene Maatschappij van Levensverzekering Conservatrix N.V. (the Company)
  (Publication made in accordance with Article 280 of Directive 2009/138/EC of the European Parliament and of the Council on the taking up and pursuit of the business of Insurance and Reinsurance (Solvency II))

(Publication made in accordance with Article 280 of Directive 2009/138/EC of the European Parliament and of the Council on the taking up and pursuit of the business of Insurance and Reinsurance (Solvency II))

3

---

| | V   Announcements |
| --- | --- |
| | PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY |
| | European Commission |
| 2021/C 29/04 | Prior notification of a concentration (Case M.10004 - EQT/Zentricity/Cajelo/Recipharm) – Candidate case for simplified procedure (
  1
  ) | 4 |
| 2021/C 29/05 | Prior notification of a concentration (Case M.10049 — Partners Group/Atlantia/Telepass) – Candidate case for simplified procedure (
  1
  ) | 6 |

V   Announcements

PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY

European Commission

2021/C 29/04

Prior notification of a concentration (Case M.10004 - EQT/Zentricity/Cajelo/Recipharm) – Candidate case for simplified procedure (
  1
  )

1

4

2021/C 29/05

Prior notification of a concentration (Case M.10049 — Partners Group/Atlantia/Telepass) – Candidate case for simplified procedure (
  1
  )

1

6

---

| | |
| --- | --- |
| | (1)   Text with EEA relevance. |

---

(1)   Text with EEA relevance.

1

| EN | |
| --- | --- |

EN

---

II Information

INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

| 26.1.2021 | EN | Official Journal of the European Union | C 29/1 |
| --- | --- | --- | --- |

26.1.2021

EN

Official Journal of the European Union

C 29/1

---

Non-opposition to a notified concentration

(Case M.10066 — Carlyle/Flender)

(Text with EEA relevance)

(2021/C 29/01)

On 19 January 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10066. EUR-Lex is the online access to European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10066. EUR-Lex is the online access to European law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---

IV Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

| 26.1.2021 | EN | Official Journal of the European Union | C 29/2 |
| --- | --- | --- | --- |

26.1.2021

EN

Official Journal of the European Union

C 29/2

---

Euro exchange rates (1)

25 January 2021

(2021/C 29/02)

1 euro =

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,2152 |
| JPY | Japanese yen | 126,06 |
| DKK | Danish krone | 7,4406 |
| GBP | Pound sterling | 0,88800 |
| SEK | Swedish krona | 10,0625 |
| CHF | Swiss franc | 1,0772 |
| ISK | Iceland króna | 157,00 |
| NOK | Norwegian krone | 10,3478 |
| BGN | Bulgarian lev | 1,9558 |
| CZK | Czech koruna | 26,080 |
| HUF | Hungarian forint | 357,33 |
| PLN | Polish zloty | 4,5409 |
| RON | Romanian leu | 4,8744 |
| TRY | Turkish lira | 8,9865 |
| AUD | Australian dollar | 1,5728 |
| CAD | Canadian dollar | 1,5459 |
| HKD | Hong Kong dollar | 9,4199 |
| NZD | New Zealand dollar | 1,6854 |
| SGD | Singapore dollar | 1,6124 |
| KRW | South Korean won | 1 340,18 |
| ZAR | South African rand | 18,4930 |
| CNY | Chinese yuan renminbi | 7,8712 |
| HRK | Croatian kuna | 7,5665 |
| IDR | Indonesian rupiah | 17 108,31 |
| MYR | Malaysian ringgit | 4,9149 |
| PHP | Philippine peso | 58,427 |
| RUB | Russian rouble | 91,6732 |
| THB | Thai baht | 36,438 |
| BRL | Brazilian real | 6,6434 |
| MXN | Mexican peso | 24,2927 |
| INR | Indian rupee | 88,6300 |

Currency

Exchange rate

USD

US dollar

1,2152

JPY

Japanese yen

126,06

DKK

Danish krone

7,4406

GBP

Pound sterling

0,88800

SEK

Swedish krona

10,0625

CHF

Swiss franc

1,0772

ISK

Iceland króna

157,00

NOK

Norwegian krone

10,3478

BGN

Bulgarian lev

1,9558

CZK

Czech koruna

26,080

HUF

Hungarian forint

357,33

PLN

Polish zloty

4,5409

RON

Romanian leu

4,8744

TRY

Turkish lira

8,9865

AUD

Australian dollar

1,5728

CAD

Canadian dollar

1,5459

HKD

Hong Kong dollar

9,4199

NZD

New Zealand dollar

1,6854

SGD

Singapore dollar

1,6124

KRW

South Korean won

1 340,18

ZAR

South African rand

18,4930

CNY

Chinese yuan renminbi

7,8712

HRK

Croatian kuna

7,5665

IDR

Indonesian rupiah

17 108,31

MYR

Malaysian ringgit

4,9149

PHP

Philippine peso

58,427

RUB

Russian rouble

91,6732

THB

Thai baht

36,438

BRL

Brazilian real

6,6434

MXN

Mexican peso

24,2927

INR

Indian rupee

88,6300

---

(1)  Source: reference exchange rate published by the ECB.

---

NOTICES FROM MEMBER STATES

| 26.1.2021 | EN | Official Journal of the European Union | C 29/3 |
| --- | --- | --- | --- |

26.1.2021

EN

Official Journal of the European Union

C 29/3

---

Winding-up proceedings

Winding-up proceedings in respect of Nederlandsche Algemene Maatschappij van Levensverzekering ‘Conservatrix’ N.V. (the ‘Company’)

(Publication made in accordance with Article 280 of Directive 2009/138/EC of the European Parliament and of the Council on the taking up and pursuit of the business of Insurance and Reinsurance (Solvency II))

(2021/C 29/03)

| Insurance undertaking | Nederlandsche Algemene Maatschappij van Levensverzekering ‘Conservatrix’ N.V. |
| --- | --- |
| Date, entry into force and nature of decision | 8 December 2020 |
| Competent authorities | Court of Amsterdam, delegated judges mr. M. de Vries and mr. A.E. de Vos |
| Supervisory authority | Court of Amsterdam, delegated judges mr. M. de Vries and mr. A.E. de Vos |
| Trustees appointed | mr. drs. W.J.M. van Andel and mr. E.L. Zetteler |
| Applicable law | Dutch Law |

Insurance undertaking

Nederlandsche Algemene Maatschappij van Levensverzekering ‘Conservatrix’ N.V.

Date, entry into force and nature of decision

8 December 2020

Competent authorities

Court of Amsterdam, delegated judges mr. M. de Vries and mr. A.E. de Vos

Supervisory authority

Court of Amsterdam, delegated judges mr. M. de Vries and mr. A.E. de Vos

Trustees appointed

mr. drs. W.J.M. van Andel and mr. E.L. Zetteler

Applicable law

Dutch Law

---

V Announcements

PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY

European Commission

| 26.1.2021 | EN | Official Journal of the European Union | C 29/4 |
| --- | --- | --- | --- |

26.1.2021

EN

Official Journal of the European Union

C 29/4

---

Prior notification of a concentration

(Case M.10004 - EQT/Zentricity/Cajelo/Recipharm)

Candidate case for simplified procedure

(Text with EEA relevance)

(2021/C 29/04)

1.

This notification concerns the following undertakings:

| — | EQT IX Collect EUR SCSp and EQT IX Collect USD SCSp (together ‘EQT IX’), part of the EQT group of private equity funds (‘EQT’, Luxembourg); |
| --- | --- |

—

EQT IX Collect EUR SCSp and EQT IX Collect USD SCSp (together ‘EQT IX’), part of the EQT group of private equity funds (‘EQT’, Luxembourg);

| — | Zentricity Holding AB (‘Zentricity’, Sweden); |
| --- | --- |

—

Zentricity Holding AB (‘Zentricity’, Sweden);

| — | Cajelo Invest Ltd (‘Cajelo’, Cyprus); and |
| --- | --- |

—

Cajelo Invest Ltd (‘Cajelo’, Cyprus); and

| — | Recipharm AB (‘Recipharm’, Sweden). |
| --- | --- |

—

Recipharm AB (‘Recipharm’, Sweden).

EQT, Zentricity and Cajelo acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of the whole of Recipharm.

The concentration is accomplished by way of public bid announced on 14 December 2020.

2.

| — | for EQT: private equity funds that invest in companies across the world, which amongst others control EQT IX, an investment fund investing primarily in Europe, with a focus on Northern Europe; |
| --- | --- |

—

for EQT: private equity funds that invest in companies across the world, which amongst others control EQT IX, an investment fund investing primarily in Europe, with a focus on Northern Europe;

| — | for Zentricity: investment company focusing on investing in pharmaceutical companies primarily in Sweden, which is controlled by private individual Thomas Eldered, who also controls the pharmaceutical companies Empros Pharma AB, Flerie Creations Ltd. and Flerie Invest AB; |
| --- | --- |

—

for Zentricity: investment company focusing on investing in pharmaceutical companies primarily in Sweden, which is controlled by private individual Thomas Eldered, who also controls the pharmaceutical companies Empros Pharma AB, Flerie Creations Ltd. and Flerie Invest AB;

| — | for Cajelo: investment company which is controlled by private individual Lars Backsell, who also controls Glims Marketing Ltd. and Rohirrim AB, a horse breeding company. |
| --- | --- |

—

for Cajelo: investment company which is controlled by private individual Lars Backsell, who also controls Glims Marketing Ltd. and Rohirrim AB, a horse breeding company.

| — | for Recipharm: contract development and manufacturing organization, providing drug development and manufacturing services globally to the pharmaceutical industry (e.g. for finished dose pharmaceuticals, active pharmaceutical ingredients and clinical trial materials for customers in the pharmaceutical industry), as well as packaging services and logistics services. |
| --- | --- |

—

for Recipharm: contract development and manufacturing organization, providing drug development and manufacturing services globally to the pharmaceutical industry (e.g. for finished dose pharmaceuticals, active pharmaceutical ingredients and clinical trial materials for customers in the pharmaceutical industry), as well as packaging services and logistics services.

3.

Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.10004 – EQT/Zentricity/Cajelo/Recipharm

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

| European Commission |
| --- |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

1

(2)  OJ C 366, 14.12.2013, p. 5.

2

---

| 26.1.2021 | EN | Official Journal of the European Union | C 29/6 |
| --- | --- | --- | --- |

26.1.2021

EN

Official Journal of the European Union

C 29/6

---

Prior notification of a concentration

(Case M.10049 — Partners Group/Atlantia/Telepass)

Candidate case for simplified procedure

(Text with EEA relevance)

(2021/C 29/05)

1.

This notification concerns the following undertakings:

| — | Partners Group AG (together with its affiliates, ‘Partners Group’, Switzerland), |
| --- | --- |

—

Partners Group AG (together with its affiliates, ‘Partners Group’, Switzerland),

| — | Atlantia SpA (‘Atlantia’, Italy), |
| --- | --- |

—

Atlantia SpA (‘Atlantia’, Italy),

| — | Telepass SpA (‘Telepass’, Italy), currently solely controlled by Atlantia (Italy) |
| --- | --- |

—

Telepass SpA (‘Telepass’, Italy), currently solely controlled by Atlantia (Italy)

Partners Group and Atlantia acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of Telepass.

The concentration is accomplished by way of purchase of shares.

2.

| — | for Partners Group: global private investment management company active in the areas of private equity, private real estate, private infrastructure and private debt; |
| --- | --- |

—

for Partners Group: global private investment management company active in the areas of private equity, private real estate, private infrastructure and private debt;

| — | for Atlantia: holding company active mainly in the toll motorway and airport infrastructure sectors in Italy, Spain, France and, to a limited extent, Poland; |
| --- | --- |

—

for Atlantia: holding company active mainly in the toll motorway and airport infrastructure sectors in Italy, Spain, France and, to a limited extent, Poland;

| — | for Telepass: active mainly in the provision of electronic tolling services in Europe and, in particular, in Italy. |
| --- | --- |

—

for Telepass: active mainly in the provision of electronic tolling services in Europe and, in particular, in Italy.

3.

Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.10049 — Partners Group/Atlantia/Telepass

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

| European Commission |
| --- |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

1

(2)  OJ C 366, 14.12.2013, p. 5.

2

---